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Abstract—Study Objective: To determine if the slope of
hase II and Phase III, and the alpha angle of the expira-
ory capnographic waveform, as measured via computer-
ecognizable algorithms, can reflect changes in bronchos-
asm in acute asthmatic non-intubated patients presenting
o the emergency department (ED). Methods: In this pro-
pective study carried out in a university hospital ED, 30
atients with acute asthma were monitored with clinical
everity scoring and peak flow measurements, and then had
nasal cannula attached for sidestream sampling of ex-
ired carbon dioxide. The capnographic waveform was
ecorded onto a personal computer card for analysis. The
atients were treated according to departmental protocols.
fter treatment, when they had improved enough for dis-
harge, a second set of results was obtained for capno-
raphic waveform recording. The pre-treatment and post-
reatment results were then compared with paired-samples
-test analysis. Results: On the capnographic waveform pre-
nd post-treatment, there was a significant difference in the
lope of Phase III (p < 0.001) and alpha angle (p < 0.001),
ut not in the Phase II slope (p  0.35). There was signif-
cant change in peak flow meter reading, but it was poorly
orrelated with all the capnographic indices. Conclusion:
he study provides some preliminary data showing that
apnographic waveform indices can indicate improvement
n airway diameter in acute asthmatics in the ED. Capno-
raphic waveform analysis presents several advantages in
hat it is effort-independent, and provides continuous mon-
toring of normal tidal respiration. With further refined
ECEIVED: 11 July 2007; FINAL SUBMISSION RECEIVED: 7 Se
CCEPTED: 13 October 2008
1
tudies, it may serve as a new method of monitoring non-
ntubated asthmatics in the ED. © 2009 Elsevier Inc.
Keywords—capnography; end tidal; acute asthma;
mergency department
INTRODUCTION
apnography comprises the continuous analysis and re-
ording of carbon dioxide (CO2) concentrations in respi-
atory gases. “Time capnography” (commonly referred
o as just capnography) is the continuous plot of levels of
xpired carbon dioxide over time, producing a capno-
ram. This allows for visual inspection of changes in
O2 concentrations by means of a waveform display,
aper recording, or even digitized measurements. It is the
nalysis of such waveforms that forms the basis of this
tudy. Capnometry, discrete measurements of carbon
ioxide concentrations, was first developed during World
ar II as a means of monitoring the internal environ-
ent of submarines (1). In the 1950s, capnometers were
sed experimentally during anesthesia to measure ex-
ired CO2. But it was only in the early 1980s that
apnometry became widely used, mainly in the anes-
hetic practice (2). Today, capnography is considered
ssential in monitoring metabolic and respiratory func-














































































2 T. A. Howe et al.
ARTICLE IN PRESSealms of anesthesia, and capnography is now used in
mergency Medicine to confirm and verify endotracheal
ube placement, monitor ventilatory status of respiratory-
mpaired patients, monitor ventilation of patients during
edation and analgesia, evaluate ventilator settings and
ircuit integrity, assess effectiveness of cardiopulmonary
esuscitation, and for early detection of changes in air-
ay resistance and circulatory collapse. Newer detection
ethods, for example, Microstream® (Novometrix,
SA) technology, has allowed for more accurate record-
ngs in smaller samples, thereby extending the use of
apnographic monitoring not only to non-intubated pa-
ients but even to pediatric patients. Much in line with
hese advances, scientists and clinicians are looking into
ther uses of capnography; among them, the analysis of
he capnographic waveform to provide information on
irway obstruction in non-intubated asthmatic patients.
The normal capnogram has an almost square-wave
attern (Figure 1) marked by alternating inspiratory
PinspCO2  0) and expiratory phases (PexpCO2) (2–4).
xpiration itself consists of three successive phases: 1) a
atency phase (Phase I), corresponding to the expiration
f the anatomical dead space (PexpCO2  0), which is
ndistinguishable from the preceding inspiration; 2) slope
hase (Phase II) marked by a very rapid rise in PexpCO2,
orresponding to expiration of mixed air; and 3) plateau
hase (Phase III), reflecting the elimination of alveolar
ir (slightly increasing PexpCO2), resulting in a peak at
he end of tidal expiration (PetCO2 close to alveolar
arbon dioxide [PACO2] tensions) (4,5). The end-tidal
eak is occasionally referred to as the end-tidal point.
his well-defined shape of the normal capnogram de-
ends on a variety of factors. Normal aerobic metabolism
ill consume oxygen and result in the production of
arbon dioxide. This will be carried by an adequately
unctioning circulatory system to the lungs where, in the
ormal lung, matched gas distribution and alveolar ven-











igure 1. The single breath capnographic waveform.xchange. In the absence of bronchial obstruction, the Ferticality of Phase II indicates a regular separation front
etween the anatomical dead space air and alveolar air.
he elimination of alveolar air is synchronous, and this is
eflected by the sudden rise in Phase II and the subse-
uent elimination of alveolar air, which is indicated by
he almost horizontal plateau of Phase III.
Asthma is a disease characterized by bronchial hyper-
eactivity, inflammatory exudates, and mucous plugging.
he hallmark of asthma is the narrowing of the smaller
irways causing obstruction to flow within the airways,
specially during expiration. In asthma, airway obstruc-
ion causes regional decreases in airflow and, conse-
uently, alveolar ventilation. This is responsible for the
parallel heterogeneity” of ventilation-perfusion ratios
V/Q ratios). Each bronchopulmonary territory is char-
cterized by its own V/Q and determining its own partial
ressure of PACO2. Alveolar air is then evacuated at
ifferent times during expiration, resulting in desynchro-
ization. This results in increased mixing of alveolar air
rom certain bronchopulmonary territories with dead
pace air from other territories. On the capnogram, this
auses deformation of the normal curve, marked by the
oss of verticality of Phase II, opening of the angle
etween Phase II and Phase III (alpha angle also known
s angle Q), and the increased inclination of Phase III
Figure 2) (4). In severe cases, the capnogram takes on a
shark’s fin” appearance. These changes in the capno-
ram are of particular interest as they indicate changes in
irflow. This may provide the means for closer, contin-
ous, and objective monitoring of airway diameter and
irflow in patients with acute asthma. You et al. con-
ucted one of the first studies on adult asthmatics and
ublished a report in 1992. They initially studied the
nd-tidal slope, which was measured manually, and re-
orted good correlations with forced expiratory volume
t 1 s (FEV1) as percentage of predicted. In this study,
hey were among the first to suggest the usefulness of
omputerization of capnogram analysis (6).
Changes in Asthma: 
a)
Phase II 
b) Increase slope of 
Phase III 






























































































ARTICLE IN PRESSThe present study was undertaken to identify capno-
raphic waveform indices that could be used in monitor-
ng non-intubated acute asthmatic patients, and to use
ntirely computer-generated algorithms to obtain and
nalyze these indices.
The objectives of this study were to: 1) Record and
nalyze the expiratory capnographic waveform via side-
tream monitoring using a nasal cannula in patients pre-
enting to the emergency department (ED) with an acute
ttack of asthma; 2) Analyze the changes in the capno-
raphic waveform after treatment, on symptomatic im-
rovement and on discharge from the ED; 3) Analyze the
apnographic waveform with indices that might be included
n a future computer algorithm for waveform analysis;




prospective case series study was conducted on pa-
ients presenting to the ED with symptoms suggestive of
sthma for a 2-month period.
etting
his study was conducted in the ED of Hospital Univer-
iti Sains Malaysia in Kubang Kerian, Malaysia. It is a
egional tertiary referral center with an ED attendance
ate exceeding 70,000 patients per year. It is also a
eaching institution and university hospital involved in
he training of undergraduate medical students as well as
roviding residency-based specialty training in many
elds, including Emergency Medicine. This study was
pproved by the departmental board review and the hos-
ital Ethics Committee.
election of Participants
atient recruitment was done by the simple sampling
ethod. Inclusion criteria for enrollment into this study
ere all adult patients who presented with symptoms of
cute breathlessness or wheezing and with a known
onfirmed history of asthma (based on medical records
otes). Those with an unclear diagnosis of asthma were
xcluded from the study. The patients selected were
nitially examined clinically by doctors working in the
D and were managed according to standard departmen-
al protocols, for example, Wright’s peak flow meter
eading (PEFR), beta-2 agonist nebulizer with oxygen sall driven, and either intravenous steroid or oral pred-
isolone. If the “need-to-treat” criteria existed, these
atients were then started on nebulizer therapy and en-
olled in the study. Patients were excluded from the study
f they presented with severe life-threatening events
here priority and attention was directed toward treat-
ent. PEFR was measured in each patient before and
fter the treatment was completed. An average of three
apnograms was then recorded using Novametrix® (No-
ametrix Inc., Wallingford, CT) capnometry. Capno-
raphic measurements were then used to aid the man-
gement of these severely ill patients. Patients were also
xcluded from the study if chronic obstructive pulmo-
ary disease (COPD) was suspected to be the primary
iagnosis, due to the irreversibility of at least some
irway obstruction that is well documented in this dis-
ase (7). All patients whose symptoms were not com-
letely relieved by nebulizer therapy or required admis-
ion were also excluded.
nterventions
he decision to treat by the attending doctor was not
nfluenced by the researcher. When the decision to start
ebulizer therapy was given, the researcher then initiated
apnographic monitoring in tandem with ongoing ther-
py. A nasal cannula, which served as the sampling port
or sidestream capnography, was applied to the patient.
hey were then directed to breathe normally. One end of
his specially designed nasal cannula provided oxygen
rom a humidified wall source (all patients in this study
ere given oxygen at a rate of 3 L/min via this nasal
annula) and the other end was connected to an aspira-
ion pump and the sampling port (8,9).
ethods and Measurement
n average of three capnograms was then recorded using
ovametrix® capnometry and stored within a Novame-
rix Novacard® personal computer card. Waveforms
ere deemed adequate when there were at least three
aveforms of regular morphology that were not de-
ormed and did not have significant artifact. Nebulizer
herapy was then started with the nasal cannula in situ.
ll patients were treated with oxygen-driven wet nebu-
izers. At the conclusion of nebulizer therapy, once the
ttending doctor had decided that the patient was “fit for
ischarge,” the post-treatment capnographic waveforms
ere again recorded and stored. Graphs were then re-
rawn from the digitized data. These digitized data were
n the form of carbon dioxide readings taken 48 times per
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ARTICLE IN PRESSnto Microsoft Excel® (Microsoft Corporation, Red-
ond, WA) format (*.xls) due to the ease of graphical
epresentation and analysis with this software.
ata Collection and Processing
ndividual graphs were then available for analysis. For
ach patient, capnograms were recorded and analyzed
re-treatment and post-treatment. We decided to study
he slope of Phase II as measured for 0.25 s from the first
oint when the measured CO2 rises above 4 mm Hg; and
he slope of Phase III as measured for 0.75 s to 0.25 s
total time 0.5 s) from the end-tidal peak to ensure the
onsistency of points of measurement. Each capnogram
as analyzed for Phase II slope (referred to subsequently
s “slope”) and Phase III slope (referred to as “plateau”).
he slopes were measured in the segments mentioned
bove by calculating a linear trendline using Microsoft
xcel Chart Wizard® (Microsoft Corporation). This was
xpressed in a y  ax  c formula where the “a”
epresented the slope of the segment analyzed. The slope
nd plateau lines together would create an obtuse angle,
nd this we referred to as “angle alpha” (angle Q). All
atients had three capnograms done for slope and plateau
nd, therefore, three values of Q were calculated. Mean
eadings were then taken of the three initial readings
Figure 3).
rimary Data Analysis
ariables were reported as mean with standard devia-
ions (SD). Statistical analysis was performed using
PSS (Version 9.0; SPSS Inc., Chicago, IL) and Stata
igure 3. Capnographic waveform indices and trendline
nalysis.Version 7.0; StataCorp LP, College Station, TX).
F
u
mong the statistical tests used were frequency analyses,
aired t-tests for comparison of means, and Wilcoxon
on-parametric signed-ranks tests for analysis of cate-
orical data. A comparison study was carried out be-
ween the PEFR readings and all the capnographic
ndices. A value of p  0.05 was considered to be
tatistically significant.
RESULTS
total of 36 patients were initially enrolled in this study.
our patients were eliminated from the study due to
nability to analyze their capnographic records, primarily
ue to lack of adequate waveforms not deformed by
rtifacts. Two other patients were excluded due to miss-
ng or incomplete data. Data from 30 patients were
ubmitted for analysis. The ages of our patients in this
tudy ranged from 10 years to 71 years, with a mean of
5.2 years and SD of  17.29 years. There were 18 male
atients and 12 female patients. Figure 4 shows the
istribution of the medications used to treat the patients
n the study. All patients were deemed fit for discharge
fter their treatment and were subsequently discharged.
one of them returned to the ED during the next 24 h.
Paired samples analysis showed a significant differ-
nce in pre- and post-treatment PEFR values (p 
.001).
End-tidal carbon dioxide (EtCO2) levels were also
ecorded pre- and post-treatment. EtCO2 levels pre-
reatment ranged from 24 to 49 mm Hg, with a mean
f 36.83 mm Hg and an SD of 4.96 mm Hg. This was
ssentially unchanged post-treatment (range 30–46 mm
g; mean 36.7 mm Hg; SD  4.49 mm Hg). Paired t-test
id not show any significant difference (p  0.871).
Gradient values for Phase II had a mean of 2.6174
SD  0.6156) pre-treatment and a mean of 2.7448
SD  0.5143) post-treatment (Figure 5); this difference
as not significant (p  0.35). Gradient values for Phase
II had a mean of 0.4419 (SD  0.2361) pre-treatment
nd a mean of 0.2301 (SD  0.0945) post-treatment




















































ARTICLE IN PRESSFigure 6); this reduction was markedly significant (p 
.001). The angle Q was calculated from the observed
radients of Phase II and Phase III. The pre-treatment
ean of 134.36 (SD  12.07) was significantly higher
han the post-treatment mean of 123.27 (SD  6.41)
p  0.001) (Figure 7).
There were poor correlations between pre-treatment
EFR readings and graphical indices; that is, between
EFR and Phase II slope (r  0.6026), Phase III slope
r  0.4328), and Q (r  0.5687). Post-treatment,
e also noted weak correlations between PEFR readings
nd graphical indices: Phase II (r  0.2149), Phase III
r  0.3870), and Q (r  0.4809). (Note: negative r
alues indicate inverse or negative correlation.) We also
ooked at the magnitude of change in PEFR and graph-
cal indices pre- and post-treatment. We then conducted
orrelation studies after generating variables of differ-
nces. There was weak correlation between the magni-
ude of change in PEFR and Phase II pre- and post-
reatment (r  0.4875). Similarly, there were only weak
egative correlations between the magnitude of change
n PEFR and Phase III (r  0.2351) and Q (r 












          Pre-treatment 
Post-treatment 
Slope 
igure 5. Phase II changes pre-treatment and post-treatmen














         Pre-Treatment 
 
Post-Treatment 
Slope igure 6. Phase III slope changes pre-treatment and post-treatme0.3085) pre- and post-treatments. In conclusion, there
ere poor correlations between the magnitudes of change in
EFR and change in graphical indices, pre-treatment and
ost-treatment.
DISCUSSION
any of the previous studies on capnography in asth-
atics have been conducted in slightly more controlled
ituations, either with asthmatic patients in histamine
hallenge tests, or with asthmatic patients whose asthma
tatus has been stable for a few hours (4,10,11). On the
ontrary, this study was conducted on asthmatic patients
resenting to the ED with an acute attack of asthma. This
tudy stands on one central pillar, that is, all patients
ithin the study population were treated by the attending
hysicians according to departmental protocol without
ny influence from the researcher. All patients in our
tudy group presented with an acute attack of asthma,
ere treated for it, and were deemed fit for discharge. We
ecorded the initial pre-treatment data after the diagnosis
17 19 21 23 25 27 29
p = 0.35 
Patients n = 30 
15 17 19 21 23 25 27 29
p < 0.001 
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ARTICLE IN PRESSf acute asthma had been made, just before the onset of
reatment. And we recorded the post-treatment data after
he patient had completed the treatment and was deemed
t for discharge. In other words, the emergency physi-
ian decided if the patient had an asthmatic attack, and
hether treatment was necessary. Treatment, usually
ith a wet nebulizer, was started according to the de-
artmental protocol. The end-point of treatment was also
ecided by this doctor and recorded when the patient was
eemed safe for discharge.
There are various options available for the assessment
f airway obstruction in the acutely ill patient with
sthma; clinical assessment and peak flow assessment
re the most commonly used within the ED. There are
bvious drawbacks to these methods. Most doctors rely
n the presence of breathlessness and an expiratory
heeze to diagnose a patient with an acute attack of
sthma, with improvement being defined as improve-
ent of symptoms and absence of wheeze. Unfortu-
ately, symptoms often tell us little about the severity of
he disease, as many patients are unable to accurately
ssess the severity of their own disease (12). Even phy-
icians may be found lacking in their judgment of degree
f airway obstruction, as Quackenboss et al. so aptly
ointed out in their study in 1991 (13). Symptomatic
mprovements are sometimes due to oxygen therapy
lone and not improvements in airway obstruction. Phys-
cal findings help physicians better assess the patient’s
ondition. Although findings like tachycardia, tachypnea,
nability to speak in full sentences, presence of wheeze
nd pulsus paradoxus, tonic contractions of inspiratory
uscles, and a low oxygen saturation level are indicative
f severe asthma, the absence of the findings do not
ecessarily indicate improvement in the patient’s status,
nd are thus of limited use.
Currently, peak flow measurement is the most widely











       Pre-Treatment 
Post-Treatment 
Slope 
igure 7. Alpha angle (Q) changes pre-treatment and post-tsed method of objectively monitoring patients with mcute asthma. Theoretically, peak flow rates are more a
unction of the diameter of the larger airways, whereas
EV1 or FEV1/forced vital capacity (FVC) reflects the
maller airways. FEV1 and FEV1/FVC are technically
ifficult to perform within the ED and involve cumber-
ome equipment. The major drawback is their effort-
ependency. The patient’s ability to perform these ma-
euvers is vital. Often in the ED, we see patients unable
o perform these maneuvers. Some are unmotivated to
erform any maneuver in the midst of their discomfort,
nxiety, and breathlessness. Many, having performed
uch tests before, claim there is a worsening of symp-
oms, especially cough, after the maneuver. Some have
uch severe bronchospasm that they are totally unable to
enerate any significant flow at all. In the context of a
tudy, this introduces bias and skewed results.
The capnographic waveform shows changes in bron-
hospasm that reflect the heterogeneity of the expired air.
his is seen as a decrease in slope of Phase II, and
ncrease of the slope of Phase III and the resultant
ncrease in the alpha angle (angle Q). Whereas gross
hanges are visible to the naked eye, for example, “shark
n” appearance, more subtle changes require measure-
ent of the slopes and angles. Because this is still a new
oncept, in all studies to date, this has been done man-
ally (4,10,11). We have taken a slightly different ap-
roach. Keeping in mind that any future application of
his concept would require computer analysis of the
apnographic waveform, we set out by using indices that
an be identified easily by computer algorithm. For the
lope of Phase II, we obtained readings for a period of
.2 s from the point when the capnographic waveform
rosses the carbon dioxide reading of 4 mm Hg, because
t is assumed that the carbon dioxide has to have come
rom the lungs to reach a level of 4 mm Hg. The second
oint identified was the end-tidal point, already a com-
17 19 21 23 25 27 29
p < 0.001 
Patients n = 30 







































































































ARTICLE IN PRESSeasured the slope of Phase III by measuring for a
eriod of 0.5 s from a point 0.25 s from the end-tidal
oint. These readings were then subjected to trend-line
nalysis, resulting in the slope. From the two slopes, the
ngle of alpha (Q) was calculated.
Kelsey and Oldham were among the first to report on
hapes of the expiratory capnogram. In their report pub-
ished in 1962, they described four kinds of shapes in
ormal and obstructive waveforms (14). Since their re-
ort, many attempts have been made to quantify these
eformations, albeit mostly in patients with COPD
15–18). Most of them, however, were done in controlled
ituations and in intubated patients (19–21). Few studies
ave been conducted in asthmatics. Some of the initial
tudies conducted in children showed changes in Phase II
nd Phase III of the expiratory capnogram after a bron-
hial challenge (22,23).
You et al., in their series of studies, have shown that
lopes of Phase II and III change demonstrably with
mprovements in airway diameter. In a continuation of
heir initial work, You et al. published a landmark article
n 1994 describing eight capnographic indices and their
orrelations with spirometric measurements (4). They
nalyzed time durations of both inspiratory and expira-
ory phases of the capnogram, measured slopes of vari-
us parts of the curve, and derived areas under the slope
t different parts of the slope. This study was ground-
reaking in that they studied adult non-intubated patients
ith acute asthma using sidestream monitoring. In this
tudy, they reported good correlations of all their indices
ith spirometric measurements. They also reported on
he restrictions and criteria in selecting waveforms for
nalysis. However, this study too was performed man-
ally in that all slope indices were measured manually
nd all derived data also were calculated manually.
hey again recognized the importance of computer
nalysis of the capnographic waveform and concluded
hat computerization of waveform indices may extend
he use of capnography to continuously monitor non-
ntubated asthmatic patients within the ED (4). They
oncluded that indices based on the latter parts of the
apnographic waveform are more sensitive and display a
tronger correlation with spirometric indices (4,6).
You et al., in a landmark study on adult asthmatics,
escribed various waveform indices such as slopes of
ifferent parts of the capnogram as well as areas sub-
ended by different parts of the curve, and correlated
hese indices with different degrees of airway obstruc-
ions quantified by spirometric findings (4). They re-
orted strong correlations of the capnographic indices
ith the spirometric parameters and suggested that cap-
ographic waveform analysis may be used in the moni-
oring of asthma. Unfortunately, the analysis of the cap-
ographic waveform is a concept still in its infancy. taveform indices that show satisfactory sensitivity
high correlation with spirometric parameters) are still
eing studied. Computer measurements of these indices,
heir memorization, and visualization in the form of trend
urves could then constitute a useful tool for asthma
onitoring. The computer analysis and display of cap-
ographic waveform indices as numerical data would
reatly simplify and thereby promote use of capnography
or the purpose of monitoring asthmatic patients during
n asthmatic attack.
In our study, we noted a similar trend, where Phase II
lopes did not show any significant change pre-treatment
s. post-treatment (p  0.35). This is in contrast to the
ignificant changes seen in Phase III (p  0.001) and
lpha angle (angle Q) (p  0.001). This may be due in
art to the mistaken selection of the point of 4 mm Hg,
ecause in many patients this did not yet show the steep
art of the Phase II slope. Another consideration is the
nclusion of the terminal part of Phase I in the slope
alculation. This may have occurred due to the slower
hanges in the transition from Phase I to Phase II seen in
idestream monitoring, mainly due to the delay during
ampling. Theoretically, the initial parts of the expiratory
apnographic waveform are most susceptible to change
f the patient consciously attempts to control respiration.
inally, the slope of Phase II may be dependent on the
nd-tidal carbon dioxide level (the height of the expi-
atory capnographic waveform) and the respiratory
ate (the width of the expiratory capnographic wave-
orm), thereby adding another factor to the analysis.
ll these factors may explain why other studies, and
urs, have found indices involving Phase II to be less
ensitive. Future studies may avoid some of these prob-
ems by selecting a higher level of CO2.
We also identified a potential problem with the Phase
II measurement criteria. In our study, Phase III was
easured for a total of 0.5 s. In patients with higher
espiratory rates, the duration of 0.5 s may bring part of
he inflection curve into the reading, resulting in inaccu-
acies in calculation. This did not occur in this study due
o the criteria of a minimum of 0.8 s duration of the
aveform for analysis. Practically speaking, setting such
riteria may exclude many waveforms for analysis and
ay not be ideal for future computer analysis. The du-
ation of Phase III taken for analysis as a percentage of
otal duration would overcome this weakness. Future
lgorithms and studies may find this to be a more helpful
ethod.
In this study, the Phase III slope and alpha angle
angle Q) changes were significantly different pre- and
ost-treatment. In other words, capnographic waveform
ndices were able to detect improvement in the patients’
ronchospasm post-treatment, as could clinical parame-
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ARTICLE IN PRESSents some advantages. We know that these specific
aveform changes indicate changes in airway obstruc-
ion. Capnography has the added advantage of being
ffort-independent, thereby reducing the influence of
he patients’ understanding and cooperation on moni-
oring parameters. This should provide a more objec-
ive evaluation of the patients’ condition, an evaluation
ess influenced by patient factors. On the other hand,
lthough we know of the specific waveform changes in
sthma, we are still uncertain which capnographic wave-
orm indices are most reflective of the situation in
sthma. There are insufficient studies at the moment to
etermine this with any degree of certainty. Therefore,
hether capnography is accurate at detecting changes in
sthma can be answered only by further study. Never-
heless, we believe that capnography has great poten-
ial as a monitoring tool in asthma due to its properties
f non-invasive, effort-independent, and continuous
onitoring.
LIMITATIONS
here are certain limitations to this study. First, the study
opulation was small. In addition, distributions with re-
pect to age and sex were not noted; however, there is no
vidence to suggest that the shape of the capnogram is
ependent on age or sex. Paired-sample analysis would
educe the influence of underlying medical conditions
nd other confounding factors.
Another potential source of bias was the selection of
aveforms for analysis; waveforms were recorded when
he morphology looked “similar” to the researcher, and
nalysis was conducted on waveforms that were not
eformed by artifacts; this was a selection bias. Although
his was a possible source of bias in this study, it also
resents a problem for computer analysis in the future;
he identification of waveforms suitable for analysis must
e foremost on the mind of the researcher writing the
lgorithm. There are several possible approaches to this
roblem. Firstly, strict exclusion criteria may be imposed
o select waveforms with artifacts. However, this runs
he risk of analyzing waveforms that may not be indic-
tive of the situation, or of having too few waveforms to
nalyze. Secondly, as Goldman and Landis have pro-
osed, recognition of the different waveform morpholo-
ies, either through neural network algorithms or as
lusters of morphologically similar waveforms, can be
rogrammed (24,25). On the whole, this will reduce the
nfluence of waveforms with artifacts or sub-optimal
aveforms, and this may then form the basis of wave-
orm selection for analysis. Thirdly, as with all single-
ource data, the problem of identification of artifacts
eeds to be addressed. The analysis of multi-source data cs usually easier and less susceptible to misdiagnosis of
rtifacts. An example in use today is the cardiac monitor.
ovement artifacts often mimic ventricular fibrillation,
ut this is usually identified as artifact if normal readings
f pulse rate and oxygen saturation are still being ob-
ained (an unlikely event in the actual event of ventric-
lar fibrillation). Here, multi-sources of data would avoid
he misdiagnosis of an event. With regards to capnogra-
hy, the addition of flow-directional information as
roposed by Bhavani-Shankar et al., or perhaps simulta-
eous flow rate recording, might be helpful (26). Although
hese are possibilities in mainstream capnography, we can-
ot imagine their use in sidestream capnography. Again,
his problem can be resolved only with further research.
Retrospectively, this study might be improved further
y introducing some minor methodological changes. A
reater number of study participants could be recruited
y prolonging the study period. A multi-center study
ould represent a more diverse study population and
ssist the investigators in recruiting more patients. The
tudy could also include all patients presenting with
cute asthma regardless of the degree of severity, either
ntubated or non-intubated, as well as admitted patients.
validation study on the use of capnographic indices in
cute asthma cases could be done by comparing them to
tandard assessment tools like peak flow meter and clin-
cal parameters.
At the present time, research into capnography wave-
orm analysis is still evolving. Multiple avenues are
eing explored. Although we are still unclear of the
uture direction of this research, and how capnographic
aveform analysis will be conducted in the future, the
otential for its use practically demands further research.
CONCLUSION
n summary, the study provides some preliminary data
howing that capnographic waveform indices can indi-
ate improvements in airway diameter in acute asthmat-
cs presenting to the ED, and that capnography poten-
ially can be used in continuous monitoring of the
sthmatic patient during an acute attack. The task now
ies in the identification of ideal waveform indices, the
omputerization of waveform analysis, and the reporting
f such indices in an easily understood and reproducible
orm. The production of a suitable algorithm, perhaps
ollowed later by the development of capnometers able
o report these indices as numerical values, would greatly
nhance the field of asthma monitoring. The ultimate
ope is that this will bring with it a better understanding
f asthma, improved management, and eventually a de-
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